Financhill
Buy
59

MANDF Quote, Financials, Valuation and Earnings

Last price:
$4.50
Seasonality move :
5.95%
Day range:
$4.50 - $4.50
52-week range:
$3.79 - $4.76
Dividend yield:
7.99%
P/E ratio:
12.73x
P/S ratio:
1.10x
P/B ratio:
1.29x
Volume:
--
Avg. volume:
32
1-year change:
7.14%
Market cap:
$2.3B
Revenue:
$1.4B
EPS (TTM):
$0.35
Period Ending 2019-12-31 2020-12-31 2021-12-31 2022-12-31 2023-12-31
Revenue -- -- -- -$826.6M $1.4B
Revenue Growth (YoY) -- -- -- -- --
 
Cost of Revenues -- -- -- -- --
Gross Profit -- -- -- -- --
Gross Profit Margin -- -- -- -- --
 
R&D Expenses -- -- -- -- --
Selling, General & Admin -- -- -- -- --
Other Inc / (Exp) -- -- -- -- --
Operating Expenses -- -- -- $27.6M $541.3K
Operating Income -- -- -- -- --
 
Net Interest Expenses -- -- -- $10.1M $12.6M
EBT. Incl. Unusual Items -- -- -- $718.6M $227.8M
Earnings of Discontinued Ops. -- -- -- -- --
Income Tax Expense -- -- -- $146.5M $54M
Net Income to Company -- -- -- $718.6M $227.8M
 
Minority Interest in Earnings -- -- -- $210.9K $216.5K
Net Income to Common Excl Extra Items -- -- -- $572.2M $174M
 
Basic EPS (Cont. Ops) -- -- -- $1.14 $0.35
Diluted EPS (Cont. Ops) -- -- -- $1.14 $0.35
Weighted Average Basic Share -- -- -- $501.8M $501.8M
Weighted Average Diluted Share -- -- -- $501.8M $501.8M
 
EBITDA -- -- -- -- --
EBIT -- -- -- $728.7M $240.3M
 
Revenue (Reported) -- -- -- -$826.6M $1.4B
Operating Income (Reported) -- -- -- -- --
Operating Income (Adjusted) -- -- -- $728.7M $240.3M
Period Ending 2020-09-30 2021-09-30 2022-09-30 2023-09-30 2024-09-30
Revenue -- -- -- $136.1M $454.8M
Revenue Growth (YoY) -- -- -- -- 234.15%
 
Cost of Revenues -- -- -- -- --
Gross Profit -- -- -- -- --
Gross Profit Margin -- -- -- -- --
 
R&D Expenses -- -- -- -- --
Selling, General & Admin -- -- -- -- --
Other Inc / (Exp) -- -- -- -- --
Operating Expenses -- -- -- -$2.1M -$3.5M
Operating Income -- -- -- -- --
 
Net Interest Expenses -- -- -- $3.5M $5.6M
EBT. Incl. Unusual Items -- -- -- $91.3M $49.7M
Earnings of Discontinued Ops. -- -- -- -- --
Income Tax Expense -- -- -- $17.2M $9.6M
Net Income to Company -- -- -- $91.2M $52.4M
 
Minority Interest in Earnings -- -- -- $108.9K -$110K
Net Income to Common Excl Extra Items -- -- -- $74.3M $40M
 
Basic EPS (Cont. Ops) -- -- -- $0.15 $0.08
Diluted EPS (Cont. Ops) -- -- -- $0.15 $0.08
Weighted Average Basic Share -- -- -- $501.8M $502.7M
Weighted Average Diluted Share -- -- -- $501.8M $502.7M
 
EBITDA -- -- -- -- --
EBIT -- -- -- $94.8M $55.3M
 
Revenue (Reported) -- -- -- $136.1M $454.8M
Operating Income (Reported) -- -- -- -- --
Operating Income (Adjusted) -- -- -- $94.8M $55.3M
Period Ending 2020-09-30 2021-09-30 2022-09-30 2023-09-30 2024-09-30
Revenue -- -- -- -- $2B
Revenue Growth (YoY) -- -- -- -- --
 
Cost of Revenues -- -- -- -- --
Gross Profit -- -- -- -- --
Gross Profit Margin -- -- -- -- --
 
R&D Expenses -- -- -- -- --
Selling, General & Admin -- -- -- -- --
Other Inc / (Exp) -- -- -- $6.6M -$6.7M
Operating Expenses -- -- -- -- $18.8M
Operating Income -- -- -- -- --
 
Net Interest Expenses -- -- -- $10.5M $13.3M
EBT. Incl. Unusual Items -- -- -- -- $232.1M
Earnings of Discontinued Ops. -- -- -- -- --
Income Tax Expense -- -- -- -- $57.1M
Net Income to Company -- -- -- -- $233.7M
 
Minority Interest in Earnings -- -- -- $325.3K -$1.4K
Net Income to Common Excl Extra Items -- -- -- -- $174.9M
 
Basic EPS (Cont. Ops) -- -- -- -- $0.35
Diluted EPS (Cont. Ops) -- -- -- -- $0.35
Weighted Average Basic Share -- -- -- -- --
Weighted Average Diluted Share -- -- -- -- --
 
EBITDA -- -- -- -- --
EBIT -- -- -- -- $245.4M
 
Revenue (Reported) -- -- -- -- $2B
Operating Income (Reported) -- -- -- -- --
Operating Income (Adjusted) -- -- -- -- $245.4M
Period Ending 2020-09-30 2021-09-30 2022-09-30 2023-09-30 2024-09-30
Revenue -- -- -- $909.9M $1.3B
Revenue Growth (YoY) -- -- -- -- --
 
Cost of Revenues -- -- -- -- --
Gross Profit -- -- -- -- --
Gross Profit Margin -- -- -- -- --
 
R&D Expenses -- -- -- -- --
Selling, General & Admin -- -- -- -- --
Other Inc / (Exp) -- -- -- $6.6M $8.6M
Operating Expenses -- -- -- -$20.5M -$2.9M
Operating Income -- -- -- -- --
 
Net Interest Expenses -- -- -- $10.5M $11.2M
EBT. Incl. Unusual Items -- -- -- $178.3M $182.3M
Earnings of Discontinued Ops. -- -- -- -- --
Income Tax Expense -- -- -- $35.7M $38.7M
Net Income to Company -- -- -- $178.7M $184.5M
 
Minority Interest in Earnings -- -- -- $325.3K -$1.4K
Net Income to Common Excl Extra Items -- -- -- $142.9M $143.4M
 
Basic EPS (Cont. Ops) -- -- -- $0.28 $0.29
Diluted EPS (Cont. Ops) -- -- -- $0.28 $0.29
Weighted Average Basic Share -- -- -- $1.5B $1.5B
Weighted Average Diluted Share -- -- -- $1.5B $1.5B
 
EBITDA -- -- -- -- --
EBIT -- -- -- $188.8M $193.5M
 
Revenue (Reported) -- -- -- $909.9M $1.3B
Operating Income (Reported) -- -- -- -- --
Operating Income (Adjusted) -- -- -- $188.8M $193.5M
Period Ending 2019-12-31 2020-12-31 2021-12-31 2022-12-31 2023-12-31
Cash and Equivalents -- -- $1B $777.1M $816.2M
Short Term Investments -- -- -- -- --
Accounts Receivable, Net -- -- -- $3.1M $1.8M
Inventory -- -- -- -- --
Prepaid Expenses -- -- -- $22.2M $23M
Other Current Assets -- -- -- -- --
Total Current Assets -- -- $1B $915.3M $937.4M
 
Property Plant And Equipment -- -- $31.2M $27.5M $30.3M
Long-Term Investments -- -- $5B $4.1B $4B
Goodwill -- -- -- $44.2M $45.5M
Other Intangibles -- -- $61.5M $14.9M $14.3M
Other Long-Term Assets -- -- -- -- --
Total Assets -- -- $18.7B $15.9B $18.1B
 
Accounts Payable -- -- -- $6.5M $4.3M
Accrued Expenses -- -- -- -- --
Current Portion Of Long-Term Debt -- -- -- -- --
Current Portion Of Capital Lease Obligations -- -- -- -- --
Other Current Liabilities -- -- -- -- --
Total Current Liabilities -- -- -- $27.5M $24M
 
Long-Term Debt -- -- $618M $374.9M $276.1M
Capital Leases -- -- -- -- --
Total Liabilities -- -- $16.7B $14.1B $16.3B
 
Common Stock -- -- $5.7M $5.4M $110.5K
Other Common Equity Adj -- -- -- -- --
Common Equity -- -- $2B $1.8B $1.8B
Total Preferred Equity -- -- -- -- --
Minority Interest, Total -- -- -- -$107.2K -$331.6K
Total Equity -- -- $2B $1.8B $1.8B
 
Total Liabilities and Equity -- -- $18.7B $15.9B $18.1B
Cash and Short Terms -- -- $1B $777.1M $816.2M
Total Debt -- -- -- $374.9M $276.1M
Period Ending 2020-09-30 2021-09-30 2022-09-30 2023-09-30 2024-09-30
Cash and Equivalents -- -- -- -- $1.3B
Short Term Investments -- -- -- -- --
Accounts Receivable, Net -- -- -- -- --
Inventory -- -- -- -- --
Prepaid Expenses -- -- -- -- --
Other Current Assets -- -- -- -- --
Total Current Assets -- -- -- -- $1.3B
 
Property Plant And Equipment -- -- -- -- $28.1M
Long-Term Investments -- -- -- -- $3.9B
Goodwill -- -- -- -- --
Other Intangibles -- -- -- -- $60.2M
Other Long-Term Assets -- -- -- -- --
Total Assets -- -- -- -- $20.1B
 
Accounts Payable -- -- -- -- --
Accrued Expenses -- -- -- -- --
Current Portion Of Long-Term Debt -- -- -- -- --
Current Portion Of Capital Lease Obligations -- -- -- -- --
Other Current Liabilities -- -- -- -- --
Total Current Liabilities -- -- -- -- --
 
Long-Term Debt -- -- -- -- $613M
Capital Leases -- -- -- -- --
Total Liabilities -- -- -- -- $18.3B
 
Common Stock -- -- -- -- $111.7K
Other Common Equity Adj -- -- -- -- --
Common Equity -- -- -- -- --
Total Preferred Equity -- -- -- -- --
Minority Interest, Total -- -- -- -- $223.4K
Total Equity -- -- -- -- $1.8B
 
Total Liabilities and Equity -- -- -- -- $20.1B
Cash and Short Terms -- -- -- -- $1.3B
Total Debt -- -- -- -- $613M
Period Ending 2019-12-31 2020-12-31 2021-12-31 2022-12-31 2023-12-31
Net Income to Stockholders -- -- -- $718.6M $227.8M
Depreciation & Amoritzation -- -- -- $9.1M $5.2M
Stock-Based Compensation -- -- -- -- --
Change in Accounts Receivable -- -- -- -- --
Change in Inventories -- -- -- -- --
Cash From Operations -- -- -- -$16.6M $303.3M
 
Capital Expenditures -- -- -- $4.4M $6M
Cash Acquisitions -- -- -- -$7.5M $21.3M
Cash From Investing -- -- -- -$11.9M $15.4M
 
Dividends Paid (Ex Special Dividend) -- -- -- -$158.2M -$162.4M
Special Dividend Paid
Long-Term Debt Issued -- -- -- -- --
Long-Term Debt Repaid -- -- -- -- --
Repurchase of Common Stock -- -- -- -- --
Other Financing Activities -- -- -- -$15.8M -$31.4M
Cash From Financing -- -- -- -$175.6M -$303.8M
 
Beginning Cash (CF) -- -- -- $968.2M $784.5M
Foreign Exchange Rate Adjustment -- -- -- -- --
Additions / Reductions -- -- -- -$204.1M $14.9M
Ending Cash (CF) -- -- -- $764.2M $799.4M
 
Levered Free Cash Flow -- -- -- -$21M $297.4M
Period Ending 2020-09-30 2021-09-30 2022-09-30 2023-09-30 2024-09-30
Net Income to Stockholders -- -- -- $91.2M $52.4M
Depreciation & Amoritzation -- -- -- -$333.1K $1.4M
Stock-Based Compensation -- -- -- -- --
Change in Accounts Receivable -- -- -- -- --
Change in Inventories -- -- -- -- --
Cash From Operations -- -- -- -$128.7M $41.8M
 
Capital Expenditures -- -- -- -$218.1K $563.7K
Cash Acquisitions -- -- -- $294.6K -$1.5M
Cash From Investing -- -- -- $512.7K -$2M
 
Dividends Paid (Ex Special Dividend) -- -- -- $247.6K -$3.8M
Special Dividend Paid -- -- -- -- --
Long-Term Debt Issued -- -- -- -- --
Long-Term Debt Repaid -- -- -- -- --
Repurchase of Common Stock -- -- -- -- --
Other Financing Activities -- -- -- $702.1K -$292.7M
Cash From Financing -- -- -- -$109M $31.3M
 
Beginning Cash (CF) -- -- -- $931.7M $849.6M
Foreign Exchange Rate Adjustment -- -- -- -- --
Additions / Reductions -- -- -- -$237.2M $71.1M
Ending Cash (CF) -- -- -- $693.1M $1.2B
 
Levered Free Cash Flow -- -- -- -$128.5M $41.2M
Period Ending 2020-09-30 2021-09-30 2022-09-30 2023-09-30 2024-09-30
Net Income to Stockholders -- -- -- -- $233.7M
Depreciation & Amoritzation -- -- -- -- $5M
Stock-Based Compensation -- -- -- -- --
Change in Accounts Receivable -- -- -- -- --
Change in Inventories -- -- -- -- --
Cash From Operations -- -- -- -- $393.1M
 
Capital Expenditures -- -- -- -- $7.2M
Cash Acquisitions -- -- -- $21.4M -$2.9M
Cash From Investing -- -- -- -- -$10M
 
Dividends Paid (Ex Special Dividend) -- -- -- -$163.3M -$181.2M
Special Dividend Paid
Long-Term Debt Issued -- -- -- -- --
Long-Term Debt Repaid -- -- -- -- --
Repurchase of Common Stock -- -- -- -- --
Other Financing Activities -- -- -- -- --
Cash From Financing -- -- -- -- -$146.8M
 
Beginning Cash (CF) -- -- -- -- --
Foreign Exchange Rate Adjustment -- -- -- -- --
Additions / Reductions -- -- -- -- $236.2M
Ending Cash (CF) -- -- -- -- --
 
Levered Free Cash Flow -- -- -- -- $386M
Period Ending 2020-09-30 2021-09-30 2022-09-30 2023-09-30 2024-09-30
Net Income to Stockholders -- -- -- $178.7M $184.5M
Depreciation & Amoritzation -- -- -- $3.9M $3.7M
Stock-Based Compensation -- -- -- -- --
Change in Accounts Receivable -- -- -- -- --
Change in Inventories -- -- -- -- --
Cash From Operations -- -- -- $187.9M $277.7M
 
Capital Expenditures -- -- -- -- $1.2M
Cash Acquisitions -- -- -- $21.4M -$2.7M
Cash From Investing -- -- -- $21.4M -$4M
 
Dividends Paid (Ex Special Dividend) -- -- -- -$163.3M -$182.1M
Special Dividend Paid -- -- -- -- --
Long-Term Debt Issued -- -- -- -- --
Long-Term Debt Repaid -- -- -- -- --
Repurchase of Common Stock -- -- -- -- --
Other Financing Activities -- -- -- -$31.6M -$292.7M
Cash From Financing -- -- -- -$305.1M -$148.1M
 
Beginning Cash (CF) -- -- -- $2.6B $2.6B
Foreign Exchange Rate Adjustment -- -- -- -- --
Additions / Reductions -- -- -- -$95.7M $125.6M
Ending Cash (CF) -- -- -- $2.5B $3B
 
Levered Free Cash Flow -- -- -- $187.9M $276.5M

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

Why Caesars’ Digital Arm May Be the Gaming Giant’s Best-Kept Secret
Why Caesars’ Digital Arm May Be the Gaming Giant’s Best-Kept Secret

It’s not often that a company with the scale and…

Will Tyson Foods Stock Bounce Back?
Will Tyson Foods Stock Bounce Back?

Tyson Foods, Inc. (NYSE:TSN) is one of the biggest food…

Will Iovance Biotherapeutics Stock Bounce Back?
Will Iovance Biotherapeutics Stock Bounce Back?

Iovance Biotherapeutics (NASDAQ:IOVA) is a fledgling pharmaceutical company that specializes…

Stock Ideas

Buy
64
Is AAPL Stock a Buy?

Market Cap: $3.8T
P/E Ratio: 42x

Buy
52
Is NVDA Stock a Buy?

Market Cap: $3.3T
P/E Ratio: 113x

Buy
55
Is MSFT Stock a Buy?

Market Cap: $3.2T
P/E Ratio: 37x

Alerts

Buy
61
QMCO alert for Dec 21

Quantum [QMCO] is up 26.28% over the past day.

Sell
46
NUKK alert for Dec 21

Nukkleus [NUKK] is down 22.94% over the past day.

Sell
1
IIPR alert for Dec 21

Innovative Industrial Properties [IIPR] is down 22.7% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock